• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS25
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Complete Heart Block (2627)
Event Date 03/02/2020
Event Type  Injury  
Manufacturer Narrative
The manufacturer is conservatively reporting this event due to the early implantation time following the perceval implant (postoperative day 5) and due to the intraoperative procedural oversizing, which may have contributed to the reported event.However, no further investigation is warranted at this time due to the patient's pre-existing conduction abnormalities which made the patient at risk for a postoperative pacemaker implant, in agreement with the physician's feedback received.Conduction disorders are common in patients with aortic valve diseases.As a result, it is common for patients to receive permanent pacemaker implantation after aortic valve replacement.Risk factors include preexisting conducting disease and preoperative aortic regurgitation.This event is, therefore, a known, inherent risk of the procedure, and it is listed among the potential adverse events in the perceval ifu.Device not explanted.
 
Event Description
On (b)(6) 2020, a patient received a perceval pvs25.It is reported that the patient received a pacemaker for an av block on postoperative day 5.A good patient outcome is reported.Per additional information received, the patient had a pre-existing bi-fascicular block, which reportedly made the patient at risk for a pacemaker implant.At the time of perceval implant, a pvs27 was initially placed, but the device was explanted before weaning the patient from bypass due to device oversizing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vercelli 13040
IT  13040
Manufacturer (Section G)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vercelli 13040
IT   13040
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, british columbia V5J 5-M1
CA   V5J 5M1
MDR Report Key9911520
MDR Text Key191914582
Report Number3005687633-2020-00111
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/19/2023
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/03/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight75
-
-